HOWL Live signaler | Maksimer profitt med Getagraph.com

KJøP 115146 min ago

@ $6.85

Utstedt: 9 feb 2024 @ 16:56

Avkastning: -7.88%

Forrige signal: feb 8 - 17:03

Forrige signal: Selg

Avkastning: 3.95 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 17:03):

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer...

Stats
Dagens volum	25 544.00
Gjennomsnittsvolum	227 943
Markedsverdi	269.67M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $-0.350 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.01
ATR14	$0.0400 (0.64%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Atkins Michael B.	Buy	35 000	Stock Option (right to buy)
2024-01-04	Atkins Michael B.	Sell	0	Common Stock
2024-01-02	Trost Timothy W.	Buy	150 000	Stock Option (right to buy)
2024-01-02	Lubman Ellen	Buy	131 900	Stock Option (right to buy)
2024-01-02	Isaacs Randi	Buy	200 000	Stock Option (right to buy)

INSIDER POWER
99.27
Last 97 transactions
Buy: 45 258 272 \| Sell: 143 550 934

Volum Korrelasjon

Lang: 0.19 (neutral)

Kort: -0.84 (strong negative)

Signal:(33.733) Neutral

Werewolf Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
RMRM	0.939
APOP	0.918
FEYE	0.897
SVOK	0.88
TLGT	0.879
SVAC	0.874
GAINL	0.874
PAIC	0.861
SYBX	0.854
TDAC	0.851

10 Mest negative korrelasjoner
MMAC	-0.959
AMRB	-0.922
BOCH	-0.893
NETE	-0.888
RGP	-0.851
SBBP	-0.823
SHSP	-0.809

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Werewolf Therapeutics, Korrelasjon - Valuta/Råvare

0.26
( neutral )

0.05
( neutral )

0.00
( neutral )

0.02
( neutral )

0.58
( weak )

0.15
( neutral )

Werewolf Therapeutics, Økonomi

Annual	2023
Omsetning:	$19.94M
Bruttogevinst:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2023
Omsetning:	$19.94M
Bruttogevinst:	$18.18M (91.15 %)
EPS:	$-1.050

FY	2022
Omsetning:	$16.40M
Bruttogevinst:	$13.89M (84.70 %)
EPS:	$-1.790

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-5.57

Financial Reports:

No articles found.

Werewolf Therapeutics,

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.